Too be clear temzolomide provides only a marginal benefit in unmethylated group if that was not understood from post above. So very very little benefit... thus GDC-0084 is attracting much attention and not just in glioblastoma.
Interview with Dr Matt Dun on DIPG research and GDC-0084, page-31
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)